Acadia: 3Q Earnings Snapshot

October 30, 2019 GMT

SAN DIEGO (AP) _ Acadia Pharmaceuticals Inc. (ACAD) on Wednesday reported a loss of $42 million in its third quarter.

The San Diego-based company said it had a loss of 29 cents per share.

The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 41 cents per share.

The drugmaker posted revenue of $94.6 million in the period, which also topped Street forecasts. Six analysts surveyed by Zacks expected $88.6 million.

Acadia shares have more than doubled since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $43.05, more than doubling in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACAD at https://www.zacks.com/ap/ACAD